Global Diagnostic and Interventional Cardiology Devices market cagr 8.9%

Diagnostic and Interventional Cardiology Devices Market

Diagnostic and Interventional Cardiology Devices

Market Scope: Industry Analysis, Market Size, Growth, Trends Till 2031

Request Sample Report

Diagnostic and Interventional Cardiology Devices

Market Size and Growth

The global Diagnostic and Interventional Cardiology Devices market is projected to reach a value of $25.3 billion by 2025, with a CAGR of 6.7%. The market is driven by the increasing prevalence of cardiovascular diseases and technological advancements in diagnostic and interventional cardiology devices. Key players include Medtronic, Boston Scientific, and Abbott.

Request Sample Report

Companies Covered (Covid 19 Impact Covered)

◍ Bracco

◍ Corindus Vascular Robotics Inc.(Siemens Healthcare)

◍ Biosense Webster Inc. (Johnson & Johnson)

◍ Auris Surgical Robotics Inc.

◍ Cook Medical

The Diagnostic and Interventional Cardiology Devices Market is highly competitive with key players such as Bracco, Corindus Vascular Robotics, Biosense Webster, Boston Scientific, and Medtronic. These companies offer innovative products for cardiac imaging, catheterization, and stenting procedures, driving market growth. Sales revenue figures: Boston Scientific - $9.8 billion, Medtronic - $30 billion.

◍ B. Braun Medical (B. Braun Melsungen)

◍ Hansen Medical Inc.

◍ Catheter Precision

◍ Boston Scientific Corp.

◍ GE Healthcare

◍ Edwards Lifescience

◍ Plc Medical Systems

◍ Kaiser Permanente

◍ Johnson & Johnson

◍ Covidien

◍ Abbott Cardiovascular

◍ Medtronic

◍ C.R. Bard

Market Segmentation

By Application

◍ Hospitals

◍ Specialty Clinics

By Product

◍ Transcatheter Angiography

Devices

◍ Intravascular Ultrasound (IVUS)

Devices

◍ Guide Wire-Based Intravascular Stenosis Assessment Or Fractional

◍ Intracardiac Echocardiography (ICE) Devices

Flow Reserve (FFR) Devices

◍ Optical Coherence Tomography (OCT) Devices

◍ Robotic-Assisted Surgical Devices